• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型螺环吲哚啉-1,2-二氮杂卓衍生物作为靶向乙酰胆碱酯酶抑制剂的抗阿尔茨海默病潜力,其取代基经过修饰。

The anti-Alzheimer potential of novel spiroindolin-1,2-diazepine derivatives as targeted cholinesterase inhibitors with modified substituents.

机构信息

Department of Chemistry, Faculty of Sciences, Persian Gulf University, Bushehr, 75169, Iran.

Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

出版信息

Sci Rep. 2023 Jul 24;13(1):11952. doi: 10.1038/s41598-023-38236-0.

DOI:10.1038/s41598-023-38236-0
PMID:37488177
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10366214/
Abstract

In this study, a new series of spiro indolin-1,2-diazepine were designed, synthesized, and screened for their cholinesterase inhibitory activities. A novel, green, high-yielding approach was constructed to synthesize spiro indolin-1,2-diazepine derivatives through a cascade reaction of different isatins, malononitrile and 1,1-enediamines (EDAMs) via sequential four-component reactions to produce the target compounds with good to excellent yields. Next the inhibitory potencies of all derivatives were determined spectroscopically at 415 nm using the modified Ellman method. The results of the in vitro screening indicated that 5l with spiroindolin-1,2-diazepine core bearing 5-NO at R and 4-OH at R was the most potent and selective AChE inhibitor with an IC value of 3.98 ± 1.07 µM with no significant inhibition against BChE while 5j was the most active analog against both AChE and BChE enzymes. The structure-activity relationships suggested the variation in the inhibitory activities of derivatives was affected by different substitutions on the indolinone ring as well as the phenyl moiety. The enzyme kinetic studies of the most potent compound 5l at five different concentrations and acetylthiocholine substrate (0.1-1 mM) by Ellman's method revealed that it inhibited AChE in a mixed mode with a K of 0.044 μM. A molecular docking study was performed via induced fit docking protocol to predict the putative binding interaction. It was shown that the moieties used in the initial structure design play a fundamental role in interacting with the enzyme's binding site. Further, molecular dynamics simulations with the Schrödinger package were performed for 5l in a complex with AChE and revealed that compound 5l formed the stable complex with the enzyme. The MTT toxicity assessments against the neuroblastoma cell line were executed, and no toxicity was seen for 5l under the tested concentrations.

摘要

在这项研究中,设计、合成了一系列新的螺环吲哚啉-1,2-二氮杂卓,并对其胆碱酯酶抑制活性进行了筛选。通过不同的靛红、丙二腈和 1,1-二乙二胺(EDAMs)的级联反应,构建了一种新颖的、绿色的、高产的方法来合成螺环吲哚啉-1,2-二氮杂卓衍生物,通过连续的四组分反应以良好到优异的产率生成目标化合物。接下来,通过改良的 Ellman 法在 415nm 处光谱测定所有衍生物的抑制活力。体外筛选结果表明,R 位带有 5-NO 和 R 位带有 4-OH 的螺环吲哚啉-1,2-二氮杂卓核心的 5l 对 AChE 的抑制作用最强且最具选择性,IC 值为 3.98±1.07µM,对 BChE 无明显抑制作用,而 5j 是对 AChE 和 BChE 酶最具活性的类似物。构效关系表明,取代基的变化会影响衍生物的抑制活性,包括吲哚酮环和苯环部分。通过 Ellman 法在五个不同浓度下和乙酰硫代胆碱底物(0.1-1mM)对最有效的化合物 5l 进行酶动力学研究,结果表明它以混合模式抑制 AChE,K 值为 0.044µM。通过诱导拟合对接方案进行了分子对接研究,以预测可能的结合相互作用。结果表明,在初始结构设计中使用的部分在与酶的结合位点相互作用中起着基本作用。此外,还使用 Schrödinger 包对 5l 与 AChE 的复合物进行了分子动力学模拟,结果表明化合物 5l 与酶形成了稳定的复合物。对神经母细胞瘤细胞系进行了 MTT 毒性评估,在测试浓度下 5l 没有显示出毒性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/7a0a35b059b3/41598_2023_38236_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/f59b7ff7311a/41598_2023_38236_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/afd6d9fb0d31/41598_2023_38236_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/8a7b5553fd00/41598_2023_38236_Sch1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/8287a390b886/41598_2023_38236_Sch2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/a7e36a4816f9/41598_2023_38236_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/d0771c8d2f97/41598_2023_38236_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/4c2d502aea20/41598_2023_38236_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/bef71adb3d9c/41598_2023_38236_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/0d737139c760/41598_2023_38236_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/d5b338f803c0/41598_2023_38236_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/19b54f9510f2/41598_2023_38236_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/dae3567e7c14/41598_2023_38236_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/7a0a35b059b3/41598_2023_38236_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/f59b7ff7311a/41598_2023_38236_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/afd6d9fb0d31/41598_2023_38236_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/8a7b5553fd00/41598_2023_38236_Sch1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/8287a390b886/41598_2023_38236_Sch2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/a7e36a4816f9/41598_2023_38236_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/d0771c8d2f97/41598_2023_38236_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/4c2d502aea20/41598_2023_38236_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/bef71adb3d9c/41598_2023_38236_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/0d737139c760/41598_2023_38236_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/d5b338f803c0/41598_2023_38236_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/19b54f9510f2/41598_2023_38236_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/dae3567e7c14/41598_2023_38236_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e0/10366214/7a0a35b059b3/41598_2023_38236_Fig11_HTML.jpg

相似文献

1
The anti-Alzheimer potential of novel spiroindolin-1,2-diazepine derivatives as targeted cholinesterase inhibitors with modified substituents.新型螺环吲哚啉-1,2-二氮杂卓衍生物作为靶向乙酰胆碱酯酶抑制剂的抗阿尔茨海默病潜力,其取代基经过修饰。
Sci Rep. 2023 Jul 24;13(1):11952. doi: 10.1038/s41598-023-38236-0.
2
Design, Synthesis and Investigation of New Diphenyl Substituted Pyridazinone Derivatives as Both Cholinesterase and Aβ-Aggregation Inhibitors.新型二苯基取代哒嗪酮衍生物作为胆碱酯酶和Aβ聚集抑制剂的设计、合成与研究
Med Chem. 2019;15(1):59-76. doi: 10.2174/1573406414666180524073241.
3
Novel N-benzylpyridinium moiety linked to arylisoxazole derivatives as selective butyrylcholinesterase inhibitors: Synthesis, biological evaluation, and docking study.新型 N-苄基吡啶鎓部分与芳基异恶唑衍生物连接作为选择性丁酰胆碱酯酶抑制剂的研究:合成、生物评价和对接研究。
Bioorg Chem. 2019 Nov;92:103192. doi: 10.1016/j.bioorg.2019.103192. Epub 2019 Aug 10.
4
Exploring 3-Benzyloxyflavones as new lead cholinesterase inhibitors: synthesis, structure-activity relationship and molecular modelling simulations.探索 3-苯甲氧基黄酮作为新型胆碱酯酶抑制剂:合成、构效关系和分子模拟研究。
J Biomol Struct Dyn. 2021 Oct;39(16):6154-6167. doi: 10.1080/07391102.2020.1803136. Epub 2020 Aug 5.
5
Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.设计并合成了一些以苯并嘧啶为核心环的新型羧酰胺和丙酰胺衍生物,并研究了它们对体外乙酰胆碱酯酶和丁酰胆碱酯酶的抑制潜力。
Bioorg Chem. 2018 Sep;79:235-249. doi: 10.1016/j.bioorg.2018.05.006. Epub 2018 May 8.
6
Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.新型亚芳基氨基噻唑基乙酮衍生物的合成、表征及胆碱酯酶抑制研究
Med Chem. 2017;13(7):648-653. doi: 10.2174/1573406413666170306113347.
7
Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.新型他克林类乙酰胆碱酯酶抑制剂有望成为治疗阿尔茨海默病的药物:喹喔啉他克林杂合体。
Mol Divers. 2022 Feb;26(1):489-503. doi: 10.1007/s11030-021-10307-2. Epub 2021 Sep 7.
8
Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors.新型奥拉帕尼类似物的合成、初步生物学评价及作为多功能 PARP-1 和胆碱酯酶抑制剂的分子对接研究。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):150-162. doi: 10.1080/14756366.2018.1530224.
9
Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.发现新的苯磺酰基嘧啶羧酸衍生物作为具有有效抗阿尔茨海默病作用的潜在多靶标药物:设计、合成、晶体结构和体外生物学评价。
Eur J Med Chem. 2021 Apr 5;215:113224. doi: 10.1016/j.ejmech.2021.113224. Epub 2021 Feb 2.
10
A cascade synthesis, in vitro cholinesterases inhibitory activity and docking studies of novel Tacrine-pyranopyrazole derivatives.新型他克林-吡喃并吡唑衍生物的级联合成、体外胆碱酯酶抑制活性及对接研究
Bioorg Med Chem Lett. 2018 Aug 1;28(14):2481-2484. doi: 10.1016/j.bmcl.2018.05.063. Epub 2018 Jun 1.

引用本文的文献

1
Electrochemical synthesis of spirooxindole-pyranopyrazole and spirooxindole-chromene derivatives as inhibitors of acetylcholinesterase.作为乙酰胆碱酯酶抑制剂的螺环氧化吲哚 - 吡喃并吡唑和螺环氧化吲哚 - 色烯衍生物的电化学合成。
BMC Chem. 2025 Sep 15;19(1):260. doi: 10.1186/s13065-025-01618-8.
2
Recent Advances in the Synthesis of Spirooxindoles: A Comprehensive Review Organized by Ring Size, Heteroatom Incorporation, and Synthetic Approaches.螺环氧化吲哚合成的最新进展:按环大小、杂原子引入及合成方法进行的全面综述
Top Curr Chem (Cham). 2025 Sep 15;383(4):42. doi: 10.1007/s41061-025-00526-8.
3
Acetylcholinesterase as a Multifunctional Target in Amyloid-Driven Neurodegeneration: From Dual-Site Inhibitors to Anti-Agregation Strategies.

本文引用的文献

1
Diastereodivergent Desymmetric Annulation to Access Spirooxindoles: Chemical Probes for Mitosis.用于构建螺环氧化吲哚的非对映发散性去对称环化反应:有丝分裂的化学探针
J Am Chem Soc. 2023 Feb 13. doi: 10.1021/jacs.2c12648.
2
Photoinduced Synthesis of Functionalized Oxacyclic Spirooxindoles Via Ring Expansion.光诱导合成功能化氧杂环螺环氧化吲哚的环扩张反应。
Org Lett. 2023 Jan 27;25(3):506-511. doi: 10.1021/acs.orglett.2c04218. Epub 2023 Jan 13.
3
The effects of microglia on tauopathy progression can be quantified using Nexopathy in silico (Nexis) models.
乙酰胆碱酯酶作为淀粉样蛋白驱动的神经退行性变中的多功能靶点:从双位点抑制剂到抗聚集策略
Int J Mol Sci. 2025 Sep 7;26(17):8726. doi: 10.3390/ijms26178726.
4
Design and evaluation of substituted cinnamoyl piperidinyl acetate derivatives as potent cholinesterase inhibitors.作为强效胆碱酯酶抑制剂的取代肉桂酰哌啶基乙酸酯衍生物的设计与评价
Sci Rep. 2025 Jun 2;15(1):19346. doi: 10.1038/s41598-025-04266-z.
5
Cinnamic acid conjugated with triazole acetamides as anti-Alzheimer and anti-melanogenesis candidates: an in vitro and in silico study.肉桂酸与三唑乙酰胺共轭作为抗阿尔茨海默病和抗黑色素生成候选物的体外和计算机模拟研究
Sci Rep. 2025 Jan 3;15(1):655. doi: 10.1038/s41598-024-83020-3.
6
Synthesis, biological evaluation and molecular modeling studies of methyl indole-isoxazole carbohydrazide derivatives as multi-target anti-Alzheimer's agents.合成、生物评价及甲基吲哚-异噁唑甲酰肼衍生物作为多靶点抗阿尔茨海默病药物的分子模拟研究。
Sci Rep. 2024 Sep 10;14(1):21115. doi: 10.1038/s41598-024-71729-0.
7
Chemoinformatics Study of Benzodiazepine-1, 2, 3-triazole Derivatives Targeting Butyrylcholinesterase.靶向丁酰胆碱酯酶的苯二氮䓬-1, 2, 3-三唑衍生物的化学信息学研究
J Fluoresc. 2025 May;35(5):3667-3680. doi: 10.1007/s10895-024-03812-8. Epub 2024 Jun 17.
8
Synthesis of novel aryl-substituted 2-aminopyridine derivatives by the cascade reaction of 1,1-enediamines with vinamidinium salts to develop novel anti-Alzheimer agents.通过 1,1-二胺与亚甲烯铵盐的级联反应合成新型芳基取代的 2-氨基吡啶衍生物,以开发新型抗阿尔茨海默病药物。
Sci Rep. 2024 Jun 14;14(1):13780. doi: 10.1038/s41598-024-64179-1.
9
Synthesis of novel hybrids of 1,2,3-triazoles-hydrazone: targeting cholinesterases and Alzheimer's related genes.合成新型 1,2,3-三唑-腙杂合体:针对胆碱酯酶和阿尔茨海默病相关基因。
Future Med Chem. 2024 Aug 2;16(15):1519-1535. doi: 10.1080/17568919.2024.2359894. Epub 2024 Jun 12.
10
Amino-7,8-dihydro-4H-chromenone derivatives as potential inhibitors of acetylcholinesterase and butyrylcholinesterase for Alzheimer's disease management; in vitro and in silico study.氨基-7,8-二氢-4H-色原酮衍生物作为治疗阿尔茨海默病的潜在乙酰胆碱酯酶和丁酰胆碱酯酶抑制剂;体外和计算机模拟研究
BMC Chem. 2024 Apr 10;18(1):70. doi: 10.1186/s13065-024-01170-x.
小胶质细胞对 tau 病进展的影响可以使用 Nexopathy 计算机模型(Nexis)进行定量评估。
Sci Rep. 2022 Dec 7;12(1):21170. doi: 10.1038/s41598-022-25131-3.
4
Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights.岩藻黄质和虾青素对抗阿尔茨海默病的多种作用:它们的药理潜力和治疗见解。
Brain Res Bull. 2023 Feb;193:11-21. doi: 10.1016/j.brainresbull.2022.11.018. Epub 2022 Nov 23.
5
Alzheimer's disease large-scale gene expression portrait identifies exercise as the top theoretical treatment.阿尔茨海默病大规模基因表达图谱表明,运动是最具理论治疗价值的方法。
Sci Rep. 2022 Oct 13;12(1):17189. doi: 10.1038/s41598-022-22179-z.
6
Design, synthesis, in silico and biological evaluations of novel polysubstituted pyrroles as selective acetylcholinesterase inhibitors against Alzheimer's disease.设计、合成、计算机模拟及新型多取代吡咯类化合物作为选择性乙酰胆碱酯酶抑制剂对阿尔茨海默病的生物评价。
Sci Rep. 2022 Sep 8;12(1):15236. doi: 10.1038/s41598-022-18224-6.
7
In-depth insights into Alzheimer's disease by using explainable machine learning approach.利用可解释的机器学习方法深入了解阿尔茨海默病。
Sci Rep. 2022 Apr 20;12(1):6508. doi: 10.1038/s41598-022-10202-2.
8
Design and synthesis of novel nitrothiazolacetamide conjugated to different thioquinazolinone derivatives as anti-urease agents.设计并合成了新型硝噻唑乙酰胺与不同硫代喹唑啉酮衍生物的轭合物作为抗脲酶剂。
Sci Rep. 2022 Feb 7;12(1):2003. doi: 10.1038/s41598-022-05736-4.
9
Novel inhibitors with sulfamethazine backbone: synthesis and biological study of multi-target cholinesterases and α-glucosidase inhibitors.具有磺胺二甲嘧啶骨架的新型抑制剂:多靶点胆碱酯酶和α-葡萄糖苷酶抑制剂的合成及生物学研究
J Biomol Struct Dyn. 2022;40(19):8752-8764. doi: 10.1080/07391102.2021.1916599. Epub 2021 May 5.
10
Multicomponent reactions as a potent tool for the synthesis of benzodiazepines.多组分反应作为合成苯并二氮杂䓬的有效工具。
Org Biomol Chem. 2021 Apr 26;19(15):3318-3358. doi: 10.1039/d0ob02600j.